Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
adjacent, advocacy, AFINITOR, AHFCA, Akeso, ALK, Alphamab, anaplastic, ANNIKE, Arabia, belief, beneficiary, BIC, Bioisland, Bold, Britain, broken, Cadillac, CDAC, ceritinib, certified, charitable, check, COMM, Compugen, concrete, constitutionality, corroborative, Crack, creation, CStone, DDL, deadline, Degradation, DEI, delta, dismissed, earthquake, EEA, EGFR, EHS, encapsulate, endothelial, energy, envafolimab, ENWEIDA, ERK, esg, excise, exit, extraterritorial, feet, fell, fight, flooded, Footnote, fortify, fundraising, gas, genomic, globe, Gloria, greenhouse, ground, GSK, gutter, headquartered, hit, Hopewell, ID, IDEA, illustrate, incubator, Ingenuity, Innocare, instated, Intensifying, Interstate, intolerant, iPSC, Janssen, JEMPERLI, journey, Julia, Lai, Lichtenstein, Mammalian, maneuver, manifest, manifesting, Mereo, MHA, MHRA, misconduct, Missouri, moratorium, mTOR, myeloablative, Nanjing, nearby, orelabrutinib, outage, overarching, overheating, overseen, Pacific, pazopanib, penpulimab, PIPL, pluripotent, POBEVCY, preempted, Princeton, processor, progenitor, rapamycin, rapid, reassessed, reexamining, refined, representation, repurposed, resuming, Retaliation, rich, safest, SAPPHIRE, Saudi, sBLA, sea, seize, Senate, Shoreline, solution, speak, Spirit, spoilage, succeed, sugemalimab, Swissmedic, tactical, Thailand, typhoon, underwritten, unnecessary, uptake, USD, vascular, VBR, vebicorvir, VEGFR, VIE, VOTRIENT, waterproof, West, YINUOKAI, YUTUO, ZEJIEMEI, zimberelimab, ZYKADIA
Removed:
abrogating, acquiree, acquirer, adapted, adenocarcinoma, affinity, al, albumin, amending, aminotransferase, anemia, anthracycline, ANZATAX, appetite, array, asthenia, atrial, Baiji, bargain, belvarafenib, bind, binimetinib, bleeding, blocking, BRAFTOVI, broadened, cancelable, CBL, Chen, cloud, cobimetinib, computing, contraindicated, copanlisib, COTELLIC, cough, count, counterparty, CR, credited, CSPC, cytotoxic, cytotoxicity, damaging, Darmstadt, deficient, deletion, diarrhea, discontinuation, durable, duvelisib, EHA, emerge, encorafenib, engineered, escalation, ESMO, expressing, facilitating, fatigue, formula, France, generating, Germany, GlaxoSmithKline, globocan, graft, hemorrhage, hereditary, hijacked, host, howard, HRD, Huajian, hypertension, hypokalemia, hypothesized, idelalisib, immunogenic, infrequent, inhibitory, injecting, Institute, Interaction, ionizing, Italy, killed, killing, lethality, liang, liposome, LIPUSU, LYNPARZA, manageable, match, mechanistically, MEKTOVI, mg, monitored, mutant, mutation, nab, nanoparticle, narrative, nausea, NCCN, neutropenia, neutrophil, nonbinding, observed, ORR, overtime, pancreatic, patrolling, PFS, ph, pharmacokinetic, phenomenon, pioneered, platelet, pneumonia, pooled, potentiate, PR, prevalent, proposal, pyrexia, ras, rash, ratio, recombination, relieved, replication, respiratory, revising, RT, RUBRACA, rucaparib, SEER, Shandong, Shenzhou, signal, simultaneously, Spain, specificity, sporadic, structured, Subtopic, survived, susceptibility, synthetic, talazoparib, TALZENNA, tangible, TAXOL, TAXOTERE, TEAE, TMZ, unamortized, unaudited, uncommon, unconsolidated, undelivered, upper, veliparib, vemurafenib, VGPR, virtually, vomiting, ZEJULA, ZELBORAF
Filing tables
Filing exhibits
Related press release
ONC similar filings
Filing view
External links